“Clinical Predictors of Response to Treatment with Tofacitinib (Janus Kinase Inhibitor) in Patients with Ankylosing Spondylitis” (2025) Indus Journal of Bioscience Research, 3(4), pp. 175–181. doi:10.70749/ijbr.v3i4.1020.